University of Wisconsin–Madison

Recent Publications

Perform a customized PubMed literature search for the Mosher Lab.

2018

  1. Roufosse FE, Johansson MWEditorial: Pathogenic Advances and Therapeutic Perspectives for Eosinophilic Inflammation. Front Med (Lausanne). 2018 Aug 31;5:243.
  2. Rusnati M, Borsotti P, Moroni E, Foglieni C, Chiodelli P, Carminati L, Pinessi D, Annis DS, Paiardi G, Bugatti A, Gori A, Longhi R, Belotti D, Mosher DF, Colombo G, Taraboletti G. The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2). Angiogenesis. 2018 Aug 30. [Epub ahead of print]
  3. Barretto KT, Swanson CM, Nguyen CLAnnis DS, Esnault SJ, Mosher DFJohansson MW. Control of cytokine-driven eosinophil migratory behavior by TGF-beta-induced protein (TGFBI) and periostin. PLoS One. 2018 Jul 26;13(7):e0201320.
  4. Kumra H, Sabatier L, Hassan A, Sakai T, Mosher DF, Brinckmann J, Reinhardt DP. Roles of fibronectin isoforms in neonatal vascular development and matrix integrity. PLoS Biol. 2018 Jul 23;16(7):e2004812.
  5. Bortnov VAnnis DS, Fogerty FJ, Barretto KT, Turton KBMosher DFMyeloid-derived growth factor is a resident endoplasmic reticulum protein. J Biol Chem. 2018 Aug 24;293(34):13166-13175.
  6. Johansson MW, Kelly EA, Nguyen CL, Jarjour NN, Bochner BS. Characterization of Siglec-8 Expression on Lavage Cells after Segmental Lung Allergen Challenge. Int Arch Allergy Immunol. 2018;177(1):16-28.
  7. Esnault S, Hebert AS, Jarjour NN, Coon JJ, Mosher DFProteomic and Phosphoproteomic Changes Induced by Prolonged Activation of Human Eosinophils with IL-3. J Proteome Res. 2018 Jun 1;17(6):2102-2111.
  8. Schnellmann R, Sack R, Hess D, Annis DSMosher DF, Apte SS, Chiquet-Ehrismann R. A Selective Extracellular Matrix Proteomics Approach Identifies Fibronectin Proteolysis by A Disintegrin-like and Metalloprotease Domain with Thrombospondin Type 1 Motifs (ADAMTS16) and Its Impact on Spheroid Morphogenesis. Mol Cell Proteomics. 2018 Jul;17(7):1410-1425.
  9. Turton KB, Wilkerson EM, Hebert AS, Fogerty FJ, Schira HM, Botros FE, Coon JJ, Mosher DFExpression of novel “LOCGEF” isoforms of ARHGEF18 in eosinophils. J Leukoc Biol. 2018 Jul;104(1):135-145.
  10. Ricklefs I, Barkas I, Duvall MG, Cernadas M, Grossman NL, Israel E, Bleecker ER, Castro M, Erzurum SC, Fahy JV, Gaston BM, Denlinger LC, Mauger DT, Wenzel SE, Comhair SA, Coverstone AM, Fajt ML, Hastie AT, Johansson MW, Peters MC, Phillips BR, Levy BD; National Heart Lung and Blood Institute’s Severe Asthma Research Program- Investigators. ALX receptor ligands define a biochemical endotype for severe asthma. JCI Insight. 2018 Mar 22;3(6). [Epub ahead of print]
  11. Peters MC, Kerr S, Dunican EM, Woodruff PG, Fajt ML, Levy BD, Israel E, Phillips BR, Mauger DT, Comhair SA, Erzurum SC, Johansson MW, Jarjour NN, Coverstone AM, Castro M, Hastie AT, Bleecker ER, Wenzel SE, Fahy JV; National Heart, Lung and Blood Institute Severe Asthma Research Program 3. Refractory airway type 2 inflammation in a large subgroup of asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol. 2018 Mar 7.  [Epub ahead of print]
  12. Tomasini-Johansson BR, Mosher DFMicrotiter assays for quantitation of assembly of plasma and cellular fibronectin. Methods Cell Biol. 2018;143:157-170.

2017

  1. Mortimer TD, Annis DS, O’Neill MB, Bohr LL, Smith TM, Poinar HN, Mosher DF, Pepperell CS. Adaptation in a Fibronectin Binding Autolysin of Staphylococcus saprophyticus. mSphere. 2017;2(6).
  2. Mosher DF, Wilkerson EM, Turton KB, Hebert AS, Coon JJ. Proteomics of Eosinophil Activation. Front Med (Lausanne). 2017 Sep 29;4:159.
  3. Kelly EA, Esnault S, Liu LY, Evans MD, Johansson MW, Mathur S, Mosher DF, Denlinger LC, Jarjour NN. Mepolizumab Attenuates Airway Eosinophil Numbers, but Not Their Functional Phenotype, in Asthma. Am J Respir Crit Care Med. 2017 Dec 1;196(11):1385-1395.
  4. Duvall MG, Barnig C, Cernadas M, Ricklefs I, Krishnamoorthy N, Grossman NL, Bhakta NR, Fahy JV, Bleecker ER, Castro M, Erzurum SC, Gaston BM, Jarjour NN, Mauger DT, Wenzel SE, Comhair SA, Coverstone AM, Fajt ML, Hastie AT, Johansson MW, Peters MC, Phillips BR, Israel E, Levy BD; National Heart, Lung, and Blood Institute’s Severe Asthma Research Program-3 Investigators. Natural killer cell-mediated inflammation resolution is disabled in severe asthma. Sci Immunol. 2017 Mar 10;2(9).
  5. Ricklefs I, Barkas I, Duvall MG, Cernadas M, Grossman NL, Israel E, Bleecker ER, Castro M, Erzurum SC, Fahy JV, Gaston BM, Denlinger LC, Mauger DT, Wenzel SE, Comhair SA, Coverstone AM, Fajt ML, Hastie AT, Johansson MW, Peters MC, Phillips BR, Levy BD; National Heart Lung and Blood Institute’s Severe Asthma Research Program-3 Investigators. ALX receptor ligands define a biochemical endotype for severe asthma. JCI Insight. 2017 Jul 20;2(14).
  6. Johansson MWEosinophil Activation Status in Separate Compartments and Association with Asthma. Front Med (Laussane). 2017 Jun 12;4:75.
  7. Johansson MW, Khanna M, Bortnov V, Annis DS, Nguyen CL, Mosher DFIL-5-stimulated eosinophils adherent to periostin undergo stereotypic morphological changes and ADAM8-dependent migration. Clin Exp Allergy. 2017 Oct;47(10):1263-1274.
  8. Esnault S, Torr EE, Bernau K, Johansson MW, Kelly EA, Sandbo N, Jarjour NN. Endogenous Semaphorin-7A Impedes Human Lung Fibroblast Differentiation. PLoS One. 2017 Jan 17;12(1):e0170207.
  9. Esnault S, Johansson MW, Kelly EA, Koenderman L, Mosher DF, Jarjour NN. IL-3 up-regulates and activates human eosinophil CD32 and αMβ2 integrin causing degranulation. Clin Exp Allergy. 2017 Apr;47(4):488-498.

2016

  1. Turton KB, Esnault S, Delain LP, Mosher DFMerging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts. J Vis Exp. 2016 Oct 9; (116).
  2. Olson AA, Evans MD, Johansson MW, Kim CH, Manthei DM, Gaumnitz EA, Mathur SK. Role of food and aeroallergen sensitization in eosinophilic esophagitis in adults. Ann Allergy Asthma Immunol. 2016 Oct;117(4):387-393.e2.
  3. Peters MC, McGrath KW, Hawkins GA, Hastie AT, Levy BD, Israel E, Phillips BR, Mauger DT, Comhair SA, Erzurum SC, Johansson MW, Jarjour NN, Coverstone AM, Castro M, Holguin F, Wenzel SE, Woodruff PG, Bleecker ER, Fahy JV; National Heart, Lung, and Blood Institute Severe Asthma Research Program. Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts. Lancet Respir Med. 2016 Jul;4(7):574-584.
  4. Denu RA, Nemcek S, Bloom DD, Goodrich AD, Kim J, Mosher DF, Hematti P. Fibroblasts and Mesenchymal Stromal/Stem Cells Are Phenotypically Indistinguishable. Acta Haematol. 2016;136(2):85-97.
  5. Johansson MW, Evans MD, Crisafi GM, Holweg CTJ, Matthews JG, Jarjour NN. Serum periostin is associated with type 2 immunity in severe asthma. J Allergy Clin Immunol. 2016 Jun;137(6):1904-1907.e2.
  6. Wilkerson EM, Johansson MW, Hebert AS, Westphall MS, Mathur SK, Jarjour NN, Schwantes EA, Mosher DF, Coon JJ. The Peripheral Blood Eosinophil Proteome. J Proteome Re. 2016 May 6; 15(5):1524-33.
  7. Metcalfe DD, Pawankar R, Ackerman SJ, Akin C, Clayton F, Falcone FH, Gleich GJ, Irani AM, Johansson MW, Klion AD, Leiferman KM, Levi-Schaffer F, Nilsson G, Okayama Y, Prussin C, Schroeder JT, Schwartz LB, Simon HU, Walls AF, Triggiani M. Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases. World Allergy Organ J. 2016 Feb 11;9:7.
  8. Nett JE, Cabezas-Olcoz J, Marchillo K, Mosher DF, Andes DR. Targeting Fibronectin To Disrupt In Vivo Candida albicans Biofilms. Antimicrob Agents Chemother. 2016 Apr 22;60(5):3152-5.
  9. Zheng M, Turton KB, Zhu F, Li Y, Grindle KM, Annis DS, Lu L, Drennan AC, Tweardy DJ, Bharadwaj U, Mosher DF, Rui L. A mix of S and ΔS variants of STAT3 enable survival of activated B-cell-like diffuse large B-cell lymphoma cells in culture. Oncogenesis. 2016 Jan 4;4:e184.